Dr. Cameron is an economist with 25 years of experience consulting to attorneys and companies involved in commercial litigation, regulatory proceedings, and other complex matters.
Her broad industry expertise includes pharmaceuticals, biologics, medical devices, motor vehicles, consumer products, software, e-commerce, cryptocurrencies, telecom, and energy. Dr. Cameron has worked on a wide array of intellectual property, false advertising, competition, and transfer pricing matters. She has analyzed damages, liability, and requests for injunctive relief. In patent disputes, Dr. Cameron has testified on both commercial success and damages. She has also testified in matters involving competition and investment incentives before the Federal Energy Regulatory Commission and state public utility commissions.
Prior to becoming a consultant, Dr. Cameron was a professor of economics at Carnegie Mellon University’s Tepper School of Business, where she taught courses in microeconomic theory, regulation, and antitrust policy.
The University of Sydney et al v. ObjectiVision Pty Ltd. (No. NSD 385 of 2014). Report on Damages.
Milwaukee Electric Tool Corporation et al v. Chervon North America, Inc. (Case No. 2-14-cv-01289-JPS). Report on Commercial Success.
Brigham and Women’s Hospital, Inc. and Investors Bio-Tech, L.P. v. Perrigo Company and L. Perrigo Company (Civ. No. 13-cv-1164). Reports on Damages and Commercial Success April 2016, Deposition May 2016, Jury Trial December 2016.
Before the Federal Energy Regulatory Commission and the Regulatory Commission of Alaska, BP Pipelines (Alaska) Inc., FERC Docket No. IS09-348, RCA Docket P-08-9